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Summary
What is already known on this topic?
Chronic infections with hepatitis C virus (HCV) are risk factors for primary
liver cancer. Lack of knowledge and awareness among health care pro-
viders, populations at high risk, and the public are barriers to HCV preven-
tion and control.
What is added by this report?
The Cherokee Nation Comprehensive Cancer Control program and the
Cherokee Nation Health Services HCV Elimination Program implemented
and evaluated activities to increase knowledge and awareness. Overall,
awareness, knowledge, ability, and intention increased among parti-
cipants in the 3 interventions.
What are the implications for public health practice?
Provider and community education interventions can improve knowledge
and awareness of liver cancer and the ability and intention to talk about it
among health care providers and community coalitions.
Abstract
Introduction
The Cherokee Nation Comprehensive Cancer Control Program
collaborated with the Cherokee Nation Hepatitis C Virus (HCV)
Elimination Program within Cherokee Nation’s Health Services to
plan and implement activities to increase knowledge and aware-
ness of liver cancer prevention among health care providers and
the  Cherokee  Nation  community.  From August  2017 to  April
2018, the 2 programs implemented liver cancer prevention inter-
ventions that focused on education of health care providers and
community members. We used descriptive statistics to analyze
data collected from a brief, retrospective pre–post survey for each
intervention. We assessed overall awareness and knowledge of liv-
er cancer and ability and intention to address it on a scale of 1 to 5.
Project Extension for Community Healthcare Outcomes didactic
sessions resulted in a 1.1-point improvement, provider education
workshops resulted in a 1.4-point improvement, and presentations
at community coalition meetings resulted in a 1.7-point improve-
ment. Our study shows that HCV interventions can be used by
public health and medical professionals interested in controlling
HCV and related diseases such as liver cancer.
Introduction
Hepatocellular carcinoma (HCC), or primary liver cancer, is the
second leading cause of cancer death worldwide among cancers
that affect both men and women (1). In the United States, chronic
infections with hepatitis B virus (HBV) or hepatitis C virus (HCV)
are strong risk factors for HCC (2). Primary liver cancer incid-
ence is increasing worldwide, including in the United States (3).
Liver cancer is more common in men than in women, and among
Asian/Pacific Islander,  Hispanic,  and American Indian/Alaska
Native populations than in other racial and ethnic groups (4).
An Institute of Medicine report in 2010 described several barriers
to HBV and HCV prevention and control efforts, including a lack
of knowledge and awareness among health care providers, popula-
tions at high risk, and the public (5). The report included recom-
mendations in 4 areas: improve viral hepatitis surveillance, im-
prove provider and community education to increase knowledge
and awareness of HBV and HCV, increase support for vaccine-
based strategies to eliminate HBV transmission, and integrate and
enhance viral hepatitis services, including risk factor screening
and serologic testing.
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The National Comprehensive Cancer Control Program (NCCCP),
funded by the Centers for Disease Control and Prevention (CDC),
provides funding and technical support for the development and
implementation of cancer control programs to create cancer con-
trol plans in all 50 states, the District of Columbia, 8 tribes and tri-
bal organizations, and 7 US territories (6). These plans guide the
work of cancer control coalitions formed by each awardee. Coali-
tions include health department staff members (at the state, tribal,
territory, US Pacific Island jurisdiction, and local levels) with ex-
pertise in cancer and their key partners, such as nonprofit organiz-
ations and community health centers. Awardee cancer control co-
alitions focus on current and emerging cancer issues in their target
population and implement strategies in prevention, early detection,
treatment, and survivorship by using policies, systems, and envir-
onmental changes to reduce the burden of cancer.
Purpose and Objectives
In 2017,  the Cherokee Nation Comprehensive Cancer  Control
(CNCCC) program initiated a partnership with the Cherokee Na-
tion Health Services (CNHS) HCV Elimination Program. The goal
of the HCV Elimination Program is to expand HCV testing and
refer patients infected with HCV for treatment. The 2 groups col-
laborated to plan, implement, and evaluate activities to increase
knowledge and awareness of HCC among health care providers
and Cherokee Nation communities. Although lead staff members
from the CNCCC program and HCV Elimination Program had
collaborated on previous work, this partnership was their first offi-
cial partnership. The objective of this study was to describe find-
ings from the evaluation of 3 interventions implemented by the 2
programs.
Intervention Approach
The 2 programs implemented liver cancer prevention interven-
tions from August 2017 through April 2018. Prevention strategies
(Table 1) aligned with provider and community education recom-
mendations in the 2010 Institute of Medicine report (5).
The HCV Elimination Program was responsible for conducting di-
dactic sessions for CNHS health care providers on HCC epidemi-
ology, diagnosis, and surveillance through the Project Extension
for  Community  Healthcare  Outcomes  (ECHO)  platform (The
Echo Model). Launched in 2003 by a liver disease physician in
Albuquerque, New Mexico, Project ECHO is a collaborative mod-
el of education and care management that brings together health
care providers to increase access to specialty treatment in rural and
underserved areas (7). The didactic sessions were delivered in a
series  of  15-minute  presentations  during  regularly  scheduled
Project  ECHO meetings  that  were  hosted  virtually  using  Mi-
crosoft Lync. The HCV Elimination Program was also respons-
ible for conducting health care provider education workshops fo-
cused on liver cancer at 8 CNHS facilities. The same slide set used
for Project ECHO didactic sessions was used for these workshops,
but instead of delivering content in multiple sessions, the entire
presentation was given in 1 workshop. The workshops were con-
ducted in person at 7 of the 8 clinics and at the hospital in the
Cherokee Nation in Oklahoma. Various health care providers, in-
cluding nurses, case managers, physicians, nurse practitioners, and
physician assistants, were invited to the workshops.
The CNCCC program was responsible for making liver cancer
prevention presentations to community coalition members at can-
cer coalition meetings. Content for each meeting was identical;
however, content delivery was tailored to each audience. Presenta-
tions focused on causes, prevention, symptoms, and diagnosis of
liver cancer. Participants represented 26 coalitions in the Chero-
kee Nation and included workers from the public school system,
local recreation centers, farmers markets, and other community or-
ganizations. The CNCCC program presented liver cancer informa-
tion at 5 coalition meetings.
Evaluation Methods
For each of the 3 interventions, CNHS assessed changes among
program participants in awareness, knowledge, ability, and inten-
tion by administering a brief, retrospective pre–post survey (8).
Survey development  was informed by materials  developed by
CNHS for provider and community presentations and outcomes of
interest to CNHS. A paper-and-pencil survey was administered at
the end of each session. For each intervention, we collected in-
formation on the number of participants and the number and types
of medical professionals attending and organizations represented.
For didactic sessions and provider education workshops, aware-
ness measured the provider’s awareness of statistics and the role
of the liver and liver cancer; knowledge measured the provider’s
knowledge of liver cancer risk factors, prevention, and signs and
symptoms of the disease; ability measured the provider’s ability to
identify patients who are at high risk for liver cancer, and inten-
tion measured the provider’s intent to speak with patients about
HCC risk and recommend screening for patients at high risk. For
the community coalition meetings, awareness measured the parti-
cipant’s awareness of the function of the liver and liver cancer
statistics; knowledge measured the participant’s knowledge of liv-
er cancer risk factors, prevention, and signs and symptoms of the
disease; ability measured the participant’s ability to speak with a
health care provider about liver cancer risk and prevention, and in-
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tention measured the participant’s intent to speak with a health
care provider about screening for HCV infection. Survey parti-
cipants marked their responses on a Likert-type scale (from 1 to 5,
with 5 indicating the best outcome).
Our analyses focused on assessing whether the interventions had
any effect on participants’ awareness, knowledge, abilities, and in-
tentions. Although pre-exposure and post-exposure data were re-
ported in the same survey, surveys were completed anonymously;
therefore, we were not able to match data for individual parti-
cipants across didactic sessions. We combined items (awareness,
knowledge, ability, and intention) to create a composite score for
each intervention. We also developed an overall composite score,
which used all survey questions pre-exposure and post-exposure to
examine change overall. We calculated mean composite scores
and standard deviations in Stata version 14 (StataCorp LLC). The
range for the overall scores was calculated as an average of the
ranges for all categories. The overall scores were calculated as an
average of all of the scores that make up the score (awareness,
knowledge, ability, intention). We used paired t tests to assess sig-
nificance of overall change from pre-exposure to post-exposure
(across awareness, knowledge, ability, intention) for each of the 3
interventions, but not for each variable of interest. We generated P
values; however, not every individual attended all 8 didactic ses-
sions. Therefore, differences between pre-exposure and post-ex-
posure might not be large for the didactic sessions, which would
cause the P values to be only slightly anticonservative. We ex-
cluded missing responses from analyses.
We collected contextual information about implementation chal-
lenges, facilitators, and lessons learned through ongoing commu-
nication between CNCCC and HCV Elimination Program staff
members and NCCCP staff  members.  Lead CNCCC and HCV
Elimination Program staff members took part in monthly technic-
al assistance calls with NCCCP staff members throughout plan-
ning and implementation of the 3 interventions. At the close of the
project, NCCCP staff members also met informally with lead staff
members from each program to discuss final thoughts and experi-
ences.
Results
Overall, awareness, knowledge, ability, and intention increased
among participants in the 3 interventions. For overall awareness,
knowledge, ability, and intention, Project ECHO didactic sessions
resulted in a 1.1-point increase (2.9 pre-exposure vs 4.0 post-ex-
posure, t70 = 3.02, P < .001), provider education workshops resul-
ted in a 1.4-point increase (2.9 vs 4.3, t101 = 4.91, P < .001), and
presentations at community coalition meetings resulted in a 1.7-
point increase (2.5 vs 4.2, t59 = 4.3, P < .001). We found improve-
ment in each variable of interest in each intervention (Table 2).
The greatest improvement in knowledge and awareness (1.2-point
increase for each) was in the Project ECHO didactic sessions. The
provider education workshops had the greatest improvement in
awareness  (1.6-point  increase),  and  the  community  coalition
presentations had the greatest improvement in knowledge (2.1-
point  increase),  closely  followed  by  awareness  (2.0-point
increase).
Health care providers also improved their ability to identify pa-
tients at high risk for viral hepatitis and HCC and improved their
intention to talk to patients about risk for the diseases. Among
community coalition participants, we found an improvement in
their ability and intention to talk to their health care provider about
their risk for liver cancer and for getting tested for viral hepatitis.
Implications for Public Health
Our study has implications for the cancer control community, in-
cluding cancer control coalitions and health care providers, be-
cause our findings address awareness and education of health care
providers, populations at risk, and the public about health risks as-
sociated with liver cancer.  The study shows how provider and
community education interventions can improve knowledge and
awareness  of  liver  cancer  and the ability  and intention to talk
about it among health care providers and community coalitions.
The improvements in each variable of interest  and overall  im-
provements were greater among participants in community coali-
tion meetings than among participants in didactic sessions and
provider education workshops. Although greater improvements
might be attributed to initially lower levels of knowledge among
community coalition participants compared with health care pro-
viders, improvements demonstrate the commitment of community
coalition members in obtaining vital information needed to best
address the needs of their target population.
Several factors facilitated implementation of our intervention, and
awareness of these factors can help others in implementing simil-
ar interventions. Regularly scheduled meeting times (ie, through
Project ECHO) with providers interested in liver cancer and who
care for relevant patient populations increased participation rates
and resulted in a captive audience and a robust discussion. A col-
laborative approach across programs facilitated access to essential
evaluation resources and expertise. An established relationship
with clinic directors  (ie,  infectious disease specialists  through
Project ECHO) helped in scheduling the workshops and ensuring
provider participation. Involving CNHS public health educators in
the coordination of coalition meetings ensured that liver cancer
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prevention presentations were included in meeting agendas and
that space was secured for each meeting. Access to audiovisual
equipment and printing resources and a meeting facilitator with a
flexible schedule helped accommodate schedules of participants.
We found numerous challenges in planning and implementing
these interventions. Developing the PowerPoint presentation for
the Project ECHO didactic sessions and provider education work-
shops was challenging in scheduling, time consumption, and com-
mitment. Finding convenient meeting times for the majority of
health care providers was difficult. Also, competing responsibilit-
ies of CNHS public health educators made it difficult for them to
dedicate a substantial amount of time to coordinating activities.
For example, they traveled for 2 or 3 hours to reach community
coalition meetings.
We learned several valuable lessons. The first is to start small.
CNHS planned and implemented 3 unique liver cancer prevention
interventions simultaneously. However, both NCCCP and HCV
Elimination Program staff members found the workload demand-
ing and in hindsight felt that focusing on just 1 or 2 activities at a
time would have been better. Second is to be realistic about re-
sources required, such as time and staffing. Planning and imple-
menting the 3 interventions took a large amount of time. CNHS
reported through interviews that it had to continuously shuffle pri-
orities to conduct the provider education sessions and complete
other time-intensive tasks. In addition, many administrative tasks
(eg, monthly reporting requirements, scheduling workshops, com-
pleting data tracking sheets) were time consuming. The CNHS
team provided an administrative staff member to complete these
tasks. The third lesson is to identify and maximize resources. Both
NCCCP and HCV Elimination Program staff members spent sub-
stantial time developing content for presentations. Greater collab-
oration among staff members in various programs and outreach to
others who might have already developed high-quality resources
that required only minor adjustments for the population of interest
could  have  increased the  efficiency of  staff  members  and de-
creased the time required to implement the interventions.
Liver cancer rates are increasing in the United States and public
health programs, including the NCCCP, should continue to build
and diversify their work in addressing viral hepatitis for liver can-
cer prevention. The CNHS cancer control and HCV elimination
programs have demonstrated a successful partnership model to ad-
dress liver cancer that can be adapted by other programs. Increas-
ing viral hepatitis and liver cancer prevention interventions among
all public health programs is an important step in lowering liver
cancer rates in the United States.
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Tables
Table 1. Liver Cancer Education Interventions for Cherokee Nation Health Care Providers and Community Coalitions, 2017–2018
Intervention Strategy Description of Activity
No. of Completed
Surveys/No. of
Attendees Participant Characteristics Time in Practice
HCV Elimination
Program
Conduct monthly
Project ECHOa
didactic sessions
Conducted 15-minute didactic
sessions during 8 Project ECHO
clinics. Topics included incidence
and prevalence of HCC, risk factors
for and diagnosis of HCC, diagnosis
of cirrhosis, and HCC surveillance.
72/83 All participants were health
care professionals; 30.6%
physicians; 20.8% nurses;
20.8% pharmacists; 8.3%
psychologists; 6.9% nurse
practitioners; 4.2% case
managers; 8.3% described
themselves as “other” health
care professional
1 week to ≥40 years
(median of 10 years in
practice)
HCV Elimination
Program
Conduct health care
provider education
workshops
Conducted 8 two-hour provider
education workshops; one at a
CNHS hospital, and 7 at CNHS
outlying clinics. Topics included
incidence and prevalence of HCC,
risk factors for and diagnosis of
HCC, diagnosis of cirrhosis, and HCC
surveillance.
108/123 All participants were health
care professionals: 35.2%
nurses; 21.3% nurse
practitioners; 17.6%
physicians; 25.9% described
themselves as “other” health
care professional
0–50 years (median of
10 years in practice)
Cherokee Nation
Comprehensive Cancer
Control Program
Conduct
presentations at
community coalition
meetings
Conducted 5 presentations at
community coalition meetings, held
in different venues in different
geographic locations. Each
presentation was approximately 30
minutes and was intended to reach
the general community.
62/78 Participants represented 26
organizations
NA
Abbreviations: CNHS, Cherokee Nation Health Services; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NA, not applicable; Project ECHO, Project Extension
for Community Healthcare Outcomes.
a Project ECHO is a collaborative model of education and care management that brings together health care providers to increase access to specialty treatment in
rural and underserved areas (https://echo.unm.edu).
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Table 2. Pre-Exposure and Post-Exposure Composite Scores for Project ECHOa Didactic Sessions, Health Care Provider Education Workshops, and Presentations at
Community Coalition Meetings
Intervention/Variable of Interest
No. of Surveys Included in
Analysis/No. of Completed
Surveys
Composite Scoresb
Pre-Exposure, Mean (SD)
[Range]
Post-Exposure, Mean (SD)
[Range]
Project ECHO didactic sessions
Awareness of the role of the liver, liver cancer, and statistics 71/72 2.98 (1.02) [1–5] 4.14 (0.73) [1–5]
Knowledge of liver cancer risk factors, prevention, and signs and
symptoms of the disease
2.72 (1.14) [1–5] 3.91 (0.80) [1–5]
Ability to identify at-risk patients 2.58 (1.05) [1–5] 3.70 (0.80) [1–5]
Intention to speak with patients about HCC risk and recommend
screening for at-risk patients
3.05 (1.13) [1–5] 4.03 (0.88) [1–5]
Overallc 2.92 (1.03) [1–5] 4.03 (0.73) [1–5]
Provider education workshops
Awareness of the role of the liver, liver cancer, and statistics 102/108 2.81 (0.81) [1–5] 4.39 (0.52) [1–5]
Knowledge of liver cancer risk factors, prevention, and signs and
symptoms of the disease
2.96 (0.80) [1–5] 4.25 (0.65) [1–5]
Ability to identify at-risk patients 2.58 (1.05) [1–5] 3.70 (0.80) [1–5]
Intention to speak with patients about HCC risk and recommend
screening for at-risk patients
3.05 (1.13) [1–5] 4.03 (0.88) [1–5]
Overallc 2.88 (0.81) [1–5] 4.25 (0.67) [1–5]
Community coalition meetings
Awareness of the role of the liver and liver cancer statistics 60/62 2.23 (0.83) [1–4] 4.25 (0.54) [3–5]
Knowledge of liver cancer risk factors, prevention, and signs and
symptoms of the disease
2.09 (0.98) [1–5] 4.20 (0.51) [3–5]
Ability to speak with a health care provider about liver cancer risk
and prevention
2.23 (1.09) [1–5] 4.14 (0.66) [1–5]
Intention to speak with a health care provider about screening for
hepatitis C virus infection
3.23 (0.99) [1–5] 4.23 (0.72) [1–5]
Overallc 2.49 (0.85) [1–5] 4.23 (0.59) [1–5]
Abbreviations: ECHO, Extension for Community Healthcare Outcomes; HCC, hepatocellular carcinoma; SD, standard deviation.
a Project ECHO is a collaborative model of education and care management that brings together health care providers to increase access to specialty treatment in
rural and underserved areas (https://echo.unm.edu).
b Participants scored their awareness, knowledge, ability, and intention by using a Likert-type scale from 1–5, with 5 being the highest score for each variable
measured.
c Paired t tests used to assess significance of overall change from pre-exposure to post-exposure (across awareness, knowledge, ability, intention) for each of the 3
interventions; P < .001 for each intervention overall.
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